Leading the Way in Life Science Technologies

GEN Exclusives

More »

GEN News Highlights

More »
October 29, 2008

DNAVision to Act as European Service Provider for Diagenic Breast Cancer and Alzheimer's Tests

  • Anticipating European approval for its breast cancer and Alzheimer’s diagnostics, DiaGenic inked a deal with DNAVision. Under the service provider agreement, DNAVision will serve as the diagnostic testing arm for DiaGenic in Europe for its blood-based gene-expression tests.

    “The key advantages of our tests are the ease of sample collection and the ability to detect the earliest signs of disease,” says DiaGenic CEO Erik Christensen, M.D., Ph.D. “However, quality control is equally important in generating provider and patient confidence. We therefore regard DNAVision as an ideal partner since their testing facilities for molecular diagnostics comply with the most advanced quality standards in Europe."